The Cigna Group: Business Overview, Financials & Competitive Analysis
The Cigna Group scores 7/10 on the AskCyborg Cyborg Score (Strong). Cigna is a defensible market leader navigating transformational healthcare market dynamics with strong fundamentals, recent regulatory clarity, and attractive analyst sentiment despite near-term margin pressures from PBM reforms. Cigna exceeded Q4 2025 analyst expectations with adjusted EPS of $8.08 versus $7.87 forecasted and revenue of $72.5 billion versus $69.9.
What is The Cigna Group's industry? The Cigna Group (cigna.com) operates in Health Insurance & Pharmacy Benefit Management (Managed Care). AskCyborg classifies The Cigna Group under Health Insurance & Pharmacy Benefit Management (Managed Care) in its company registry.
The Cigna Group provides insurance and related products and services in the United States through two main segments: Cigna Healthcare offering medical, pharmacy, behavioral health, and dental products, and Evernorth H...
Cyborg Score thesis
Cigna is a defensible market leader navigating transformational healthcare market dynamics with strong fundamentals, recent...
Read the full analyst-debate transcript →Get the Latest The Cigna Group Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeThe Cigna Group Overview
Pro stress-test →The Cigna Group provides insurance and related products and services in the United States through two main segments: Cigna Healthcare offering medical, pharmacy, behavioral health, and dental products, and Evernorth Health Services providing pharmacy benefits, specialty pharmacy, and care management solutions. The company operates as a vertically integrated healthcare player serving employers, government organizations, and individuals through insurance brokers, direct distribution, and public/private exchanges.
Strategic Profile
Pro stress-test →Cigna has recently reached a landmark FTC settlement in early February 2026 resolving a contentious lawsuit regarding insulin pricing, effectively ending years of litigation surrounding allegations that the company's pharmacy benefit manager Express Scripts manipulated drug formularies. The company secured regulatory stability by agreeing to overhaul business practices without admitting wrongdoing or paying direct financial penalties, though the agreement mandates a total transparency makeover requiring decoupling earnings from drug list prices—fundamentally altering the traditional PBM profit model.
Competitive Landscape
Pro stress-test →Cigna competes alongside CVS and UnitedHealth as one of the "Big Three" PBM giants facing ongoing FTC regulatory pressure and industry transformation toward transparent healthcare models. The company's integrated health insurance and PBM platform, combined with scale and Express Scripts assets, provides competitive positioning in the employer-sponsored and Medicare markets despite near-term margin pressures from regulatory compliance costs.
Industry Context
The Cigna Group operates in Health Insurance & Pharmacy Benefit Management (Managed Care).
Key facts
Founded: 1792 · Headquarters: Bloomfield, Connecticut · Employees: 72,398 · Revenue: $275B · Market cap: $76.88B